Literature DB >> 27617567

Tuberous Sclerosis Complex: A Roadmap for Future Research.

Anna Jeong1.   

Abstract

Investigators from the NINDS and the Tuberous Sclerosis Alliance sponsored a workshop in March 2015, which joined basic scientists and clinicians with expertise in various aspects of Tuberous Sclerosis Complex (TSC), in order to assess the current state of TSC research and to set future goals.

Entities:  

Keywords:  Autism; Epilepsy; Tuberous Sclerosis Complex; mTOR

Year:  2016        PMID： 27617567      PMCID： PMC5005288          DOI： 10.15844/pedneurbriefs-30-7-1

Source DB:  PubMed          Journal:  Pediatr Neurol Briefs        ISSN： 1043-3155


  6 in total

1.  Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.

Authors:  David Neal Franz; Elena Belousova; Steven Sparagana; E Martina Bebin; Michael Frost; Rachel Kuperman; Olaf Witt; Michael H Kohrman; J Robert Flamini; Joyce Y Wu; Paolo Curatolo; Petrus J de Vries; Vicky H Whittemore; Elizabeth A Thiele; James P Ford; Gaurav Shah; Helene Cauwel; David Lebwohl; Tarek Sahmoud; Sergiusz Jozwiak
Journal:  Lancet       Date:  2012-11-14       Impact factor: 79.321

2.  Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.

Authors:  John J Bissler; J Christopher Kingswood; Elżbieta Radzikowska; Bernard A Zonnenberg; Michael Frost; Elena Belousova; Matthias Sauter; Norio Nonomura; Susanne Brakemeier; Petrus J de Vries; Vicky H Whittemore; David Chen; Tarek Sahmoud; Gaurav Shah; Jeremie Lincy; David Lebwohl; Klemens Budde
Journal:  Lancet       Date:  2013-03-09       Impact factor: 79.321

3.  Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference.

Authors:  Mustafa Sahin; Elizabeth P Henske; Brendan D Manning; Kevin C Ess; John J Bissler; Eric Klann; David J Kwiatkowski; Steven L Roberds; Alcino J Silva; Coryse St Hillaire-Clarke; Lisa R Young; Mark Zervas; Laura A Mamounas
Journal:  Pediatr Neurol       Date:  2016-04-02       Impact factor: 3.372

4.  The natural history of epilepsy in tuberous sclerosis complex.

Authors:  Catherine J Chu-Shore; Philippe Major; Susana Camposano; David Muzykewicz; Elizabeth A Thiele
Journal:  Epilepsia       Date:  2009-12-22       Impact factor: 5.864

Review 5.  Prevalence of autism spectrum disorder phenomenology in genetic disorders: a systematic review and meta-analysis.

Authors:  Caroline Richards; Christopher Jones; Laura Groves; Jo Moss; Chris Oliver
Journal:  Lancet Psychiatry       Date:  2015-09-01       Impact factor: 27.083

6.  Clinical Electroencephalographic Biomarker for Impending Epilepsy in Asymptomatic Tuberous Sclerosis Complex Infants.

Authors:  Joyce Y Wu; Jurriaan M Peters; Monisha Goyal; Darcy Krueger; Mustafa Sahin; Hope Northrup; Kit Sing Au; Gary Cutter; E Martina Bebin
Journal:  Pediatr Neurol       Date:  2015-09-25       Impact factor: 3.372
  6 in total
  1 in total

Review 1.  Tuberous sclerosis complex: review based on new diagnostic criteria.

Authors:  Larissa Karine Leite Portocarrero; Klícia Novais Quental; Luciana Paula Samorano; Zilda Najjar Prado de Oliveira; Maria Cecília da Matta Rivitti-Machado
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.